A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Cilomilast | Cilomilast. Group: Biochemicals. Alternative Names: cis-4-Cyano-4- [3- (cyclopentyloxy) -4-methoxyphenyl] cyclohexanecarboxylic acid; cis-4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-4-cyanocyclohexane-1-carboxylic acid; Ariflo. Grades: Highly Purified. CAS No. 153259-65-5. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C20H25NO4. US Biological Life Sciences. |  Worldwide |
| Cilomilast | ?95% (HPLC). Group: Fluorescence/luminescence spectroscopy. |  |
| Cilomilast | Selective phosphodiesterase 4 (PDE4) inhibitor. Antiasthmatic; used in treatment of chronic obstructive pulmonary disease. Uses: Phosphodiesterase 4 inhibitors. Synonyms: SB 207499; SB-207499; SB207499. Cilomilast; Ariflo. Grade: 0.98. CAS No. 153259-65-5. Molecular formula: C20H25NO4. Mole weight: 343.423. |  |
| Cilomilast-d5 | An isotope labelled of Cilomilast. Cilomilast is a selective phosphodiesterase-4 inhibitor and can be used for the treatment of respiratory disorders. Grade: 95% by HPLC; 98% atom D. Molecular formula: C20H20D5NO4. Mole weight: 348.45. | |
| Cilostamide | Cilostamide is a selective and potent PDE3 inhibitor, with IC50s of 27 nM and 50 nM for PDE3A and PDE3B, respectively, and has antithrombotic and anti-intimal hyperplastic activity. Uses: Scientific research. Group: Signaling pathways. Alternative Names: OPC3689. CAS No. 68550-75-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-101312. |  |
| Cilostamide | Cilostamide is a selective and specific inhibitor of type III phosphodiesterase (PDE3). It shows moderate selectivity for PDE3A isozyme and PDE3B. It increases intracellular cAMP and inhibits ADP-induced platelet aggregation. It has an antithrombotic effect. Uses: Phosphodiesterase inhibitors. Synonyms: Cilostamide; OPC 3689; OPC-3689; OPC3689; N-Cyclohexyl-N-methyl-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide; 6-[3-(N-Cyclohexyl-N-methylcarbamoyl)propoxy]quinolin-2[1H]-one. CAS No. 68550-75-4. Molecular formula: C20H26N2O3. Mole weight: 342.44. | |
| Cilostamide | phosphodiesterase inhibitor. Group: Fluorescence/luminescence spectroscopy. | |
| Cilostamide | Cilostamide. Group: Biochemicals. Grades: Purified. CAS No. 68550-75-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Cilostamide - CAS 68550-75-4 | A cell-permeable selective inhibitor of cGMP-inhibited phosphodiesterase (PDE III; IC?? = 70 nM). Group: Fluorescence/luminescence spectroscopy. | |
| Cilostazol | Cilostazol (OPC 13013) is a potent and selective inhibitor of phosphodiesterase (PDE) 3A , the isoform of PDE 3 in the cardiovascular system, with an IC 50 of 0.2 μM [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: OPC 13013. CAS No. 73963-72-1. Pack Sizes: 10 mM * 1 mL; 50 mg; 100 mg. Product ID: HY-17464. | |
| Cilostazol | Cilostazol. Group: Biochemicals. Grades: Purified. CAS No. 73963-72-1. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Cilostazol | Cilostazol is a potent cyclic nucleotide phosphodiesterase type 3 (PDE3) inhibitor with IC50 of 0.2 μM and inhibitor of adenosine uptake. Uses: Bronchodilator agents. Synonyms: AT2266; CI919; Pd107779; NSC629661; AT 2266; CI 919; Pd 107779; NSC 629661; AT-2266; CI-919; Pd-107779; NSC-629661. Grade: >98%. CAS No. 73963-72-1. Molecular formula: C20H27N5O2. Mole weight: 369.46. | |
| Cilostazol | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C20H27N5O2. CAS No. 73963-72-1. Prepack ID 81559665-1g. Molecular Weight 369.46. See USA prepack pricing. |  |
| Cilostazol-[d11] | Cilostazol-[d11] is the labelled analogue of Cilostazol. Cilostazol is a medication used to help the symptoms of intermittent claudication in peripheral vascular disease. Cilostazol is a potent cyclic nucleotide phosphodiesterase type 3 (PDE3) inhibitor with IC50 of 0.2 μM and inhibitor of adenosine uptake. Synonyms: Cilostazol-d11; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone-d11; OPC-13013-d11; Pletal-d11. Grade: 97% by CP; 98% atom D. CAS No. 1073608-02-2. Molecular formula: C20H16D11N5O2. Mole weight: 380.53. | |
| Cilostazol-d11 (OPC-13013-d11, Pletal-d11, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone) | A potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake. Has antimitogeni, antithrombotic, vasodilatory and cardiotonic properties in vivo. Also affects lipid levels in vivo. Group: Biochemicals. Alternative Names: OPC-13013-d11;Pletal-d11;6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Cilostazol-D2 | Cilostazol-D2. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1073608-03-3. Molecular formula: C20H25D2N5O2. Mole weight: 371.48. Catalog: APB1073608033. | |
| Cilostazol-[d4] | Cilostazol-[d4] is the labelled analogue of Cilostazol. Cilostazol is a medication used to help the symptoms of intermittent claudication in peripheral vascular disease. Cilostazol is a potent cyclic nucleotide phosphodiesterase type 3 (PDE3) inhibitor with IC50 of 0.2 μM and inhibitor of adenosine uptake. Synonyms: Cilostazol D4; 6-[4-(1-Cyclohexyl-d4-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone; Pletal-d4. Grade: 98%; ≥95% atom D. CAS No. 1215541-47-1. Molecular formula: C20H23D4N5O2. Mole weight: 373.49. | |
| Cilostazol-D6 | Cilostazol-D6. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1246641-05-3. Molecular formula: C20H21D6N5O2. Mole weight: 375.51. Catalog: APB1246641053. | |
| Cilostazol Impurity 12-D11 | Cilostazol Impurity 12-D11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1073608-13-5. Molecular formula: C20H14D11N5O2. Mole weight: 378.52. Catalog: APB1073608135. | |
| Cilostazol (OPC-13013, Pletal, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone) | A potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake. Has antimitogeni, antithrombotic, vasodilatory and cardiotonic properties in vivo. Also affects lipid levels in vivo. Group: Biochemicals. Alternative Names: OPC-13013, Pletal, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone. Grades: Highly Purified. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Cilostazol Related Compound A | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Cilostazol related compound C | 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone, is an impurity of Cilostazol, a potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake. Synonyms: 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone. Grade: > 95%. CAS No. 865792-18-3. Molecular formula: C31H45N9O2. Mole weight: 575.75. | |
| Ciluprevir | Ciluprevir is used experimentally in the treatment of hepatitis C. It is manufactured by Boehringer Ingelheim Pharma GmbH & Co. kg and developed under the research code of BILN-2061. It is targeted against NS2-3 protease. Synonyms: BILN 2061; BILN-2061; BILN2061; BILN-2061ZW; BILN2061ZW; BILN 2061ZW; Ciluprevir. Grade: >98%. CAS No. 300832-84-2. Molecular formula: C40H50N6O8S. Mole weight: 774.93. | |
| CIM0216 | CIM0216, a synthetic TRPM3 ligand, acts as a potent and selective agonist of TRPM3. CIM0216 exhibits selectivity for TRPM3 over TRPM1, TRPM2 and TRPM4-8. CIM0216 acts in a TRPM3-dependent manner to induce pain and evoke neuropeptide release from sensory nerve terminals in vitro. CIM0216 is a powerful tool for studies of the physiological functions of TRPM3, and can be used for neurogenic inflammation research [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1031496-06-6. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-110220. | |
| CIM 0216 | CIM 0216 has been found to be a selective TRPM3 agonist and could stimulate the release of insulin from pancreatic islet cells. Synonyms: CIM-0216; CIM 0216; CIM0216; 3,4-Dihydro-N-(5-methyl-3-isoxazolyl)-α-phenyl-1(2H)-quinolineacetamide. Grade: ≥98% by HPLC. CAS No. 1031496-06-6. Molecular formula: C21H21N3O2. Mole weight: 347.41. | |
| Ci-MAM-A24 | Ci-MAM-A24 is a synthetic antimicrobial peptide derived from a peptide precursor from immune cells of the marine invertebrate Ciona intestinalis. It has been shown to be potently active against representatives of Gram-positive and Gram-negative bacteria by permeabilising their cytoplasmic membrane. | |
| Cimaterol | Cimaterol is a β-adrenergic agonist, related to Clenbuterol and Mabuterol. It is also a repartitioning agent. Uses: Adrenergic beta-agonists. Synonyms: Cimater; 2-Amino-5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]benzonitrile; CL 263780; Cimaterolum. Grade: 98%. CAS No. 54239-37-1. Molecular formula: C12H17N3O. Mole weight: 219.28. | |
| Cimaterol | A β-adrenergic agonist, related to Clenbuterol and Mabuterol. A repartitioning agent. Group: Biochemicals. Alternative Names: 2-Amino-5- [1-hydroxy-2- [ (1-methylethyl) amino] ethyl] benzonitrile. Grades: Highly Purified. CAS No. 54239-37-1. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Cimaterol-d7 | analytical standard. Group: Drugs & metabolitespesticides & metabolitespesticides & metabolitespharmaceutical toxicology. Alternative Names: 2-Amino-5-[1-hydroxy-2-[[1-(methyl-d3)ethyl-1,2,2,2-d4]amino]ethyl]benzonitrile, Cimaterol-d7, Cimaterol D7 (isopropyl D7),Benzonitrile, 2-amino-5-[1-hydroxy-2-[[1-(methyl-d3)ethyl-1,2,2,2-d4]amino]ethyl]-, D7-Cimaterol. | |
| Cimaterol-d7 | A labeled β-adrenergic agonist, related to Clenbuterol and Mabuterol. A repartitioning agent. Group: Biochemicals. Alternative Names: 2-Amino-5- [1-hydroxy-2- [ (1-methylethyl-d7) amino] ethyl] benzonitrile. Grades: Highly Purified. CAS No. 1228182-44-2. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Cimaterol-[d7] | Cimaterol-[d7] is the labelled analogue of Cimaterol, which is a β-adrenergic agonist, related to Clenbuterol and Mabuterol. Synonyms: Cimaterol-D7; 2-Amino-5-(1-hydroxy-2-isopropyl-D7-amino-ethyl)-benzonitrile; 2-Amino-5-[1-hydroxy-2-[(1-methylethyl-d7)amino]ethyl]benzonitrile. Grade: 98%; ≥99% atom D. CAS No. 1228182-44-2. Molecular formula: C12H10D7N3O. Mole weight: 226.33. | |
| Cimbuterol | Cimbuterol is a β-adrenergic agonist. Synonyms: 2-Amino-5-(2-tert-butylamino-1-hydroxyethyl)-benzonitrile. CAS No. 54239-39-3. Molecular formula: C13H19N3O. Mole weight: 233.315. | |
| Cimbuterol | analytical standard. Group: Amphetamines / stimulants standardspharma & vet compounds & metabolitesstandards for environmental regulatory methodspharma & vet compounds & metabolites. Alternative Names: Cimbuterol. | |
| Cimbuterol | A β-adrenergic agonist. Group: Biochemicals. Alternative Names: 2-Amino-5- [2- [ (1, 1-dimethylethyl) amino] -1-hydroxyethyl] benzonitrile. Grades: Highly Purified. CAS No. 54239-39-3. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Cimbuterol-d9 | A labeled intermediate for Cimaterol-d7 , a β-adrenergic agonist. Group: Biochemicals. Alternative Names: 2-Amino-5- [2- [ (1, 1-dimethylethyl-d9) amino] -1-hydroxyethyl] benzonitrile. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Cimbuterol-[d9] | Cimbuterol-[d9] is the labelled analogue of Cimbuterol, which is a β-adrenergic agonist. Synonyms: Cimbuterol-D9; 2-Amino-5-(2-tert-butylamino-D9-1-hydroxyethyl)-benzonitrile; 2-Amino-5-[2-[(1,1-dimethylethyl-d9)amino]-1-hydroxyethyl]benzonitrile; Cimbuterol-(tert-butyl-d9). Grade: 95% by HPLC; 98% atom D. CAS No. 1246819-04-4. Molecular formula: C13H10D9N3O. Mole weight: 242.37. | |
| Cimbuterol-(tert-butyl-d9) | analytical standard. Group: Amphetamines / stimulants standards. | |
| Cimdelirsen | Cimdelirsen is a novel, ligand-conjugated, hepatic-targeted investigative antisense molecule designed to reduce growth hormone receptor (GHr) synthesis, thereby inhibiting deleterious effects of growth hormone (GH) hypersecretion and reducing circulating insulin-like growth factor-1 (IGF-1) levels in acromegaly patients. Synonyms: ISIS 766720; ISIS-766720; ISIS766720; IONIS-GHR-LRx; all-P-ambo-5'-O-(28-[(2-acetamido-2-deoxy-β-D-galactopyranosyl)oxy]-16,16-bis{[3-({6-[(2-acetamido-2-deoxy-β-D-galactopyranosyl)oxy]hex-yl}amino)-3-oxopropoxy]methyl}-1-hydroxy-1,10,14,21-tetraoxo-2,18-dioxa-9,15,22-triaza-1λ5-phosphaoctacosan-1-yl)-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'→5')-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytid. CAS No. 2131025-82-4. | |
| Cimetidine | Cimetidine, a histamine congener, competitively inhibits histamine binding to histamine H2 receptors. Uses: Adjuvants, immunologic; analgesics, non-narcotic; anti-ulcer agents; enzyme inhibitors; histamine h2 antagonists. Synonyms: SKF-92334; SKF 92334; SKF92334. Grade: >98%. CAS No. 51481-61-9. Molecular formula: C10H16N6S. Mole weight: 252.34. | |
| Cimetidine | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standardspharma & vet compounds & metabolitespharma & vet compounds & metabolitesapi standardsbritish pharmacopoeiaeuropean pharmacopoeia (ph. eur.)pharmaceutical toxicologypharmacopoeial standards. Alternative Names: N-Cyano-N'-methyl-N''-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]guanidine, Ulcofalk, N-Cyano-N'-methyl-N''-[2-((4-methyl-5-imidazolyl)-methylthio)ethyl]guanidine, Cimetum, SKF 92334, Tratul, NSC 335308, Peptol, Edalene, Ulcedin, Biomet, Ulcomedina, Eureceptor, Histodil, Acibilin, Ulcerfen, Tametin, Dyspamet,Cimetidine, Cimetag, Ulcomet, Ulcimet, SKF-92334, Cimal, Tagamet, N-Cyano-N'-methyl-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine, Gastromet, Acinil, Ulhys, Ulcedine. | |
| Cimetidine | Cimetidine (SKF-92334) is an orally active and inverse histamine H2 receptor antagonist with a K i of 0.6 μM. Cimetidine is a gastric acid reducer, and can be used for duodenal and gastric ulcers research. Cimetidine has anti-cancer and anti-inflammatory activity [1] [2] [5]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: SKF-92334. CAS No. 51481-61-9. Pack Sizes: 10 mM * 1 mL; 100 mg; 1 g; 5 g; 10 g. Product ID: HY-14289. | |
| Cimetidine | United States Pharmacopeia (USP) Reference Standard. Uses: For analytical and research use. Group: Pharmacopeia & metrological institutes standards; pharma & vet compounds & metabolites; pharma & vet compounds & metabolites; api standards; british pharmacopoeia; european pharmacopoeia (ph. eur.); pharmaceutical toxicology; pharmacopoeial standards. Alternative Names: N-Cyano-N'-methyl-N''-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]guanidine, Ulcofalk, N-Cyano-N'-methyl-N''-[2-((4-methyl-5-imidazolyl)-methylthio)ethyl]guanidine, Cimetum, SKF 92334, Tratul, NSC 335308, Peptol, Edalene, Ulcedin, Biomet, Ulcomedina, Eureceptor, Histodil, Acibilin, Ulcerfen, Tametin, Dyspamet,Cimetidine, Cimetag, Ulcomet, Ulcimet, SKF-92334, Cimal, Tagamet, N-Cyano-N'-methyl-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine, Gastromet, Acinil, Ulhys, Ulcedine. CAS No. 51481-61-9. Pack Sizes: 200MG. IUPAC Name: 2-cyano-1-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine. Molecular formula: C10H16N6S. Mole weight: 252.34. Catalog: APS51481619. SMILES: CNC(=NC#N)NCCSCc1nc[nH]c1C. Format: Neat. | |
| Cimetidine | 5g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C10H16N6S. CAS No. 51481-61-9. Prepack ID 70637565-5g. Molecular Weight 252.34. See USA prepack pricing. | |
| Cimetidine | Competitive histamine H2-receptor antagonist which inhibits gastric acid secretion and reduces pepsin output. Group: Biochemicals. Alternative Names: N-Cyano-N'-methyl-N''-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]-guanidine;Acibilin; Acinil; Biomet; Cimal; Cimetag; Cimetum; Dyspamet; Edalene; Eureceptor; Gastromet; Histodil; Peptol; SKF 92334; Tagamet; Tametin; Tratul; Ulcedin. Grades: Highly Purified. CAS No. 51481-61-9. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Cimetidine Amide Dihydrochloride | Impurity C of Cimetidine. Group: Biochemicals. Alternative Names: [ (Methylamino) [ [2- [ [5-methyl-1H-imidazol-4-yl) methyl] thio] ethyl] amino] methylene] - urea Dihydrochloride. Grades: Highly Purified. CAS No. 52568-80-6. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Cimetidine Amide Dihydrochloride | Cimetidine Amide Dihydrochloride. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Cimetidine Amide Dihydrochloride, SKF-92422-A2,Cimetidine Hydrochloride Imp. C (EP), Cimetidine Hydrochloride Imp. C (EP) as Dihydrochloride, Cimetidine Imp. C (EP), Ph Eur Cimetidine Impurity C, Cimetidine Imp. C (EP) as Dihydrochloride, 1-[(Methylamino)[[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethyl]amino]methylene]urea Dihydrochloride. CAS No. 52568-80-6. IUPAC Name: [methylamino-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethylamino]methylidene]urea;dihydrochloride. Molecular formula: C10H18N6OS.2ClH. Mole weight: 343.28. Catalog: APS52568806. SMILES: Cl.Cl.CNC(=NC(=O)N)NCCSCc1nc[nH]c1C. Format: Neat. | |
| Cimetidine-[d3] | Cimetidine-[d3] is the labelled analogue of Cimetidine. Cimetidine is a competitive histamine H2-receptor antagonist which inhibits gastric acid secretion and reduces pepsin output. Synonyms: Cimetidine D3; N-Cyano-N'-methyl-d3-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine; Acibilin-d3; Acinil-d3; Cimal-d3; Cimetag-d3; Cimetum-d3; Edalened3; Peptol-d3; Tagamet-d3; Ulcedin-d3. Grade: ≥98% by HPLC; ≥99% atom D. CAS No. 1185237-29-9. Molecular formula: C10H13D3N6S. Mole weight: 255.35. | |
| Cimetidine-d3 (N-Cyano-N-methyl-d3-N- [2- [ [ (5-methyl-1H-imidazol-4-yl) methyl] thio] ethyl] guanidine, . SKF-9233-4-d3, Acibilin-d3, Acinil-d3, Cimal-d3, Cimetag-d3, Cimetum-d3, Edalened3, Peptol-d3, Tagamet-d3, Ulcedin-d3) | Competitive histamine H2-receptor antagonist which inhibits gastric acid secretion and reduces pepsin output. Group: Biochemicals. Alternative Names: N-Cyano-N-methyl-d3-N- [2- [ [ (5-methyl-1H-imidazol-4-yl) methyl] thio] ethyl] guanidine; SKF-9233-4-d3; Acibilin-d3; Acinil-d3; Cimal-d3; Cimetag-d3; Cimetum-d3; Edalened3; Peptol-d3; Tagamet-d3; Ulcedin-d3. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Cimetidine EP Impurity B | Cimetidine EP Impurity B is an impurity of Cimetidine, a pharmacological agent categorized under the esteemed H2-receptor antagonist lineage. The paramount significance of Cimetidine lies in its prescription dominion, predominantly directed towards efficaciously treating ailments encompassing gastroesophageal reflux maladies, peptic ulcers and analogous afflictions permeating the gastrointestinal domain. Synonyms: Methyl 3-cyano-1-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl]ethyl]-carbamimidate. Grade: > 95%. CAS No. 138035-55-9. Molecular formula: C10H15N5OS. Mole weight: 253.32. | |
| Cimetidine EP Impurity C | Cimetidine Amide Dihydrochloride is an impurity of Cimetidine. Synonyms: Cimetidine Amide Dihydrochloride; [(Methylamino)[[2-[[5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]amino]methylene]- urea Dihydrochloride. Grade: > 95%. CAS No. 52568-80-6. Molecular formula: C10H20Cl2N6OS. Mole weight: 343.28. | |
| Cimetidine EP Impurity F | Cimetidine EP Impurity F is an impurity of Cimetidine, a medication used for gastric ulcer alleviation, gastroesophageal reflux disease (GERD) therapy and Zollinger-Ellison syndrome therapy. Grade: > 95%. CAS No. 55272-86-1. Molecular formula: C16H24N8S2. Mole weight: 392.55. | |
| Cimetidine EP Impurity G | N-Cyano-N',N'-dimethyl-guanidine is an impurity in the synthesis of Cimetidine, a competitive histamine H2-receptor antagonist which inhibits gastric acid secretion and reduces pepsin output. It is also used in the preparation of histamine H2 receptor antagonists. Synonyms: 1-Cyano-2,3-dimethyl-guanidine; 1,3-Dimethyl-2-cyanoguanidine; 2-Cyano-1,3-dimethylguanidine; N-Cyano-N',N''-dimethylguanidine. Grade: > 95%. CAS No. 31857-31-5. Molecular formula: C4H8N4. Mole weight: 112.13. | |
| Cimetidine EP Impurity H | N-Cyano-3-(cyanoamino)-N'-methyl-7,8-dithia-2,4,11-triazadodec-2-en-12-imidamide is an impurity of Cimetidine, an H2-receptor antagonist that is used for the treatment and prevention of stress-induced gastroduodenal lesions. Synonyms: N-Cyano-3-(cyanoamino)-N'-methyl-7,8-dithia-2,4,11-triazadodec-2-en-12-imidamide. Grade: > 95%. CAS No. 74886-59-2. Molecular formula: C10H18N8S2. Mole weight: 314.43. | |
| Cimetidine EP Impurity I HCl | Cimetidine EP Impurity I HCl is an impurity of Cimetidine. Cimetidine is a consequential therapeutic agent employed in the therapy of gastric ulcers and gastroesophageal reflux disease. Grade: > 95%. CAS No. 38603-74-6. Molecular formula: C6H11N2OCl. Mole weight: 162.62. | |
| Cimetidine EP Impurity J DiHCl | Cimetidine EP Impurity J DiHCl is an impurity in the synthesis of Cimetidine, a medication primarily used for treating peptic ulcers, gastroesophageal reflux disease (GERD) and other related conditions. Synonyms: 2-[[(5-Methyl-1H-imidazol-4-yl)methyl]thio]-ethanamine DiHydrochloride; 4-[(2-Aminoethyl)thiomethyl]-5-methylimidazole DiHydrochloride; 5-[[(2-Aminoethyl)thio]methyl]-4-methylimidazole DiHydrochloride. Grade: > 95%. CAS No. 38603-72-4. Molecular formula: C7H15Cl2N3S. Mole weight: 244.19. | |
| Cimetidine hydrochloride | Pharmaceutical Secondary Standard; Certified Reference Material. Group: Pharmacopeia & metrological institutes standards. | |
| Cimetidine hydrochloride | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standardseuropean pharmacopoeia (ph. eur.)pharmacopoeial standards. Alternative Names: 2-Cyano-1-methyl-3-[-2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl]ethyl]guanidine hydrochloride,Cimetidine Hydrochloride. | |
| Cimetidine Impurity 3 | Cimetidine Impurity 3 is an impurity of Cimetidine employed in treating gastric ulcers, gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome. Grade: > 95%. CAS No. 208447-53-4. Molecular formula: C11H20N8S2. Mole weight: 328.46. | |
| Cimetidine Sulfoxide | Cimetidine Sulfoxide. Group: Biochemicals. Alternative Names: N-Cyano-N'-methyl-N''- [2- [ [ (4-methyl-1H-imidazol-5-yl) methyl] sulfinyl] ethyl] guanidine; (±)-Cimetidine S-Oxide; SKF 92452. Grades: Highly Purified. CAS No. 54237-72-8. Pack Sizes: 100mg. Molecular Formula: C10H16N6OS , Molecular Weight: 268.339999999999. US Biological Life Sciences. | Worldwide |
| Cimetidine Sulfoxide | Cimetidine Sulfoxide is a metabolite of the H2-receptor antagonist Cimetidine. Cimetidine Sulfoxide is detected in the blood and urine of patients with kidney diseases. Synonyms: N-Cyano-N'-methyl-N''-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]sulfinyl]ethyl]guanidine; (±)-Cimetidine S-Oxide; SKF 92452. Grade: > 95%. CAS No. 54237-72-8. Molecular formula: C10H16N6OS. Mole weight: 268.34. | |
| Cimetidine Sulfoxide-d3 | Cimetidine Sulfoxide-d3. Group: Biochemicals. Alternative Names: N-Cyano-N'-methyl-N''- [2- [ [ (4-methyl-1H-imidazol-5-yl) methyl] sulfinyl] ethyl] guanidine-d3; (±)-Cimetidine S-Oxide-d3; SKF 92452-d3. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C10H13D3N6OS , Molecular Weight: 271.36. US Biological Life Sciences. | Worldwide |
| CIMETIDINE SULPHOXIDE DIHYDROCHLORIDE | CIMETIDINE SULPHOXIDE DIHYDROCHLORIDE. Uses: Designed for use in research and industrial production. Additional or Alternative Names: CIMETIDINE SULPHOXIDE DIHYDROCHLORIDE;cimetidine sulfoxide;1-[2-[(5-Methyl-1H-imidazole-4-yl)methylsulfinyl]ethyl]-3-methyl-2-cyanoguanidine;1-Cyano-3-methyl-2-[2-[[(5-methyl-1H-imidazole-4-yl)methyl]sulfinyl]ethyl]guanidine;2-Cyano-1-methyl-3-[2-[[(5-me. Product Category: Heterocyclic Organic Compound. CAS No. 54237-72-8. Product ID: ACM54237728. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Cimetropium Bromide | Cimetropium Bromide (DA-3177) is a mAChR antagonist for long-term treatment of irritable bowel syndrome. Uses: Scientific research. Group: Signaling pathways. Alternative Names: DA-3177. CAS No. 51598-60-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg. Product ID: HY-U00106. | |
| Cimicidanol 3-Arabinoside | Cimicidanol 3-Arabinoside. Group: Biochemicals. Grades: Plant Grade. CAS No. 161207-05-2. Pack Sizes: 10mg. Molecular Formula: C35H52O9, Molecular Weight: 616.78. US Biological Life Sciences. | Worldwide |
| Cimicidanol 3- O-α-L -arabinoside | Cimicidanol 3- O-α-L -arabinoside. Group: Biochemicals. CAS No. 161207-05-2. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Cimicifugoside | Cimicifugoside. Group: Biochemicals. Grades: Plant Grade. CAS No. 66176-93-0. Pack Sizes: 20mg. Molecular Formula: C37H54O11, Molecular Weight: 674.82. US Biological Life Sciences. | Worldwide |
| Cimicoxib | Cimicoxib is a non-steroidal anti-inflammatory drug (NSAID) that selectively inhibits COX-2. It is used in veterinary medicine for the control of pain and inflammation associated with osteoarthritis in dogs. Synonyms: UR-8880; UR 8880; UR8880. Grade: >98%. CAS No. 265114-23-6. Molecular formula: C16H13ClFN3O3S. Mole weight: 381.8. | |
| Cimicoxib | Cimicoxib (CX) is an orally active potent and selective COX-2 (cyclo-oxygenase-2) inhibitor. Cimicoxib exhibits promising anti-inflammatory and analgesic activity. The PK parameters of Cimicoxib in dogs given precise (2 mg/kg) and approximate doses (1.95-2.5 mg/kg) are similar [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: UR-8880. CAS No. 265114-23-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-100516. | |
| Cimicoxib | Cimicoxib. Group: Biochemicals. Alternative Names: 4-[4-Chloro-5-(3-fluoro-4-methoxyphenyl)-1H-imidazol-1-yl]benzenesulfonamide; 4-[4-Chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]benzenesulfonamide; UR 8880. Grades: Highly Purified. CAS No. 265114-23-6. Pack Sizes: 25mg. Molecular Formula: C16H13ClFN3O3S, Molecular Weight: 381.81. US Biological Life Sciences. | Worldwide |
| Cimifugin | Cimifugin, isolated from Peucedanum schottii, displays low to moderate inhibition towards AChE and BChE (3.12 and 21.63%, respectively) at 200ug ml-1.[1]Cimifugin appears to inhibit FITC-induced type 2 allergic contact dermatitis and its mechanism might be related to regulating the balance of Th1 /Th2 by inhibiting type 2 cytokines.[2]. Group: Biochemicals. Alternative Names: 2,3-Dihydro-4-methoxy-7-(hydroxymethyl)-2-(1-hydroxy-1-methylethyl)-5H-furo[3,2-g][1]benzopyran-5-one; Cimitin; 1-Naphtyl β-D-galactopyranoside. Grades: Highly Purified. CAS No. 37921-38-3. Pack Sizes: 5mg, 10mg, 25mg. Molecular Formula: C16H18O6, Molecular Weight: 306.31. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
